• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母乳喂养可能是家族性多发性硬化症个体的一个保护因素。一项基于人群登记的病例对照研究。

Exclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A population registry-based case-control study.

机构信息

Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Clinic of Neurology, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

Mult Scler Relat Disord. 2024 Feb;82:105392. doi: 10.1016/j.msard.2023.105392. Epub 2023 Dec 19.

DOI:10.1016/j.msard.2023.105392
PMID:38159366
Abstract

BACKGROUND

Multiple sclerosis (MS) is an immune-mediated disease that affects the central nervous system, which most likely results from the interplay between environmental and genetic factors. The aim of our study was to assess the effect of breastfeeding on the risk of developing familial multiple sclerosis (fMS) in persons with positive MS history, being the first such investigation performed in fMS cohort.

METHODS

A case-control study based on the Belgrade population MS Registry was conducted. Cases for the sporadic MS (sMS) control group were randomly selected from the Registry, and matched with individuals with fMS at a ratio of 1:1. Spouses of the persons with fMS were included as a healthy control (HC) group. A specific questionnaire that was previously validated was used to obtain the data. To evaluate risk factors associated with breastfeeding for fMS occurrence compared with sMS and HC, multinomial regression analysis was performed to compute the relative risk ratios (RRR) along with 95% confidence intervals (95% CI). The analysis was afterwards repeated, stratified by sex. Both models were adjusted for potential confounding factors.

RESULTS

A total of 393 participants were included in our case-control study, 131 per group. There were more individuals who were exclusively breastfed longer than six months in the sMS group compared to fMS group (RRR 2.01, 95% CI 1.22-3.32). After stratification by sex, exclusive breastfeeding was shown to be a protective factor for fMS only in male population, for individuals breastfed ≥4 months. The results of both the main and stratified analysis remained robust after adjustment.

CONCLUSION

Our study findings indicate that breastfeeding reduces the risk of MS in infants with family history of the disease, although this protective effect may be limited to the male population. Further investigation into the differences in risk factors between fMS and sMS is warranted to gain a more comprehensive understanding of the disease.

摘要

背景

多发性硬化症(MS)是一种影响中枢神经系统的免疫介导性疾病,它很可能是由环境和遗传因素相互作用引起的。我们的研究目的是评估母乳喂养对有 MS 家族史的个体患家族性多发性硬化症(fMS)的风险的影响,这是在 fMS 队列中进行的首次此类研究。

方法

我们进行了一项基于贝尔格莱德人群 MS 登记处的病例对照研究。从登记处随机选择散发性 MS(sMS)对照组的病例,并以 1:1 的比例与 fMS 个体相匹配。fMS 个体的配偶被纳入健康对照组(HC)。使用先前经过验证的特定问卷获取数据。为了评估与 fMS 发生相关的母乳喂养风险因素与 sMS 和 HC 相比,我们进行了多变量回归分析,以计算相对风险比(RRR)及其 95%置信区间(95%CI)。随后,按性别进行了分层分析。两个模型都调整了潜在的混杂因素。

结果

我们的病例对照研究共纳入了 393 名参与者,每组 131 名。sMS 组中,与 fMS 组相比,有更多的个体进行了更长时间(≥6 个月)的纯母乳喂养(RRR 2.01,95%CI 1.22-3.32)。按性别分层后,仅在男性人群中,≥4 个月纯母乳喂养被证明是 fMS 的保护因素。主要和分层分析的结果在调整后仍然稳健。

结论

我们的研究结果表明,母乳喂养可降低有 MS 家族史的婴儿患 MS 的风险,但这种保护作用可能仅限于男性人群。进一步研究 fMS 和 sMS 之间的危险因素差异,有助于更全面地了解该疾病。

相似文献

1
Exclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A population registry-based case-control study.母乳喂养可能是家族性多发性硬化症个体的一个保护因素。一项基于人群登记的病例对照研究。
Mult Scler Relat Disord. 2024 Feb;82:105392. doi: 10.1016/j.msard.2023.105392. Epub 2023 Dec 19.
2
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran.伊朗马尔卡齐省家族性多发性硬化症的流行病学及其与散发性形式的比较。
Mult Scler Relat Disord. 2022 Dec;68:104231. doi: 10.1016/j.msard.2022.104231. Epub 2022 Oct 8.
3
Familial vs sporadic multiple sclerosis in the Israeli population: Differences in ethnicity distribution and disease progression, with anticipation in successive generations.以色列人群中家族性与散发性多发性硬化症的对比:在种族分布和疾病进展方面的差异,并在连续几代人中出现预期。
Mult Scler Relat Disord. 2024 Jul;87:105604. doi: 10.1016/j.msard.2024.105604. Epub 2024 Apr 3.
4
Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.伊朗家族性多发性硬化症的流行病学:基于国家登记的研究。
BMC Neurol. 2022 Mar 5;22(1):76. doi: 10.1186/s12883-022-02609-1.
5
Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease.希腊的家族性多发性硬化症:与散发性疾病相比的独特临床和影像学特征。
Clin Neurol Neurosurg. 2018 Oct;173:144-149. doi: 10.1016/j.clineuro.2018.08.021. Epub 2018 Aug 13.
6
The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study.父母近亲婚配和家族聚集与多发性硬化症发病的关系:病例对照研究。
Eur J Med Res. 2024 Oct 18;29(1):503. doi: 10.1186/s40001-024-02094-x.
7
Earlier age of symptom onset in younger generation of familial cases of multiple sclerosis.多发性硬化症家族病例中青年一代发病年龄更早。
Neurol Sci. 2024 Sep;45(9):4463-4469. doi: 10.1007/s10072-024-07512-w. Epub 2024 Apr 9.
8
Disease onset in familial and sporadic multiple sclerosis in Argentina.阿根廷家族性和散发性多发性硬化症的疾病发作情况。
Mult Scler Relat Disord. 2016 Mar;6:54-56. doi: 10.1016/j.msard.2016.01.004. Epub 2016 Jan 19.
9
Breastfeeding and Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis of Observational Studies.母乳喂养与多发性硬化症风险:观察性研究的系统评价和荟萃分析。
Neuroepidemiology. 2022;56(6):391-401. doi: 10.1159/000526895. Epub 2022 Sep 12.
10
Shared breastfeeding & other early multiple sclerosis risk factors: A case-control study.母乳喂养与其他早期多发性硬化症风险因素:一项病例对照研究。
Mult Scler Relat Disord. 2021 May;50:102812. doi: 10.1016/j.msard.2021.102812. Epub 2021 Feb 4.

引用本文的文献

1
The Role of Phytochemicals in Managing Neuropathic Pain: How Much Progress Have We Made?植物化学物质在治疗神经性疼痛中的作用:我们取得了多大进展?
Nutrients. 2024 Dec 16;16(24):4342. doi: 10.3390/nu16244342.